← Open Payments lookup

KATIE FEE: Open Payments

NPI 1407443658 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,050 in 49 payments from 17 companies in 2025. Trend: 2023 $943 · 2024 $773 · 2025 $1,050

Food & beverage: $1,050
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$294
Lilly USA, LLC8$129
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$124
Astellas Pharma US Inc4$81
ABBVIE INC.3$62
GlaxoSmithKline, LLC.2$60
Amgen Inc.4$60
Novo Nordisk Inc3$58
Sumitomo Pharma America, Inc.2$32
Medtronic, Inc.1$27

Products named: BREZTRI, XIFAXAN, FARXIGA, Veozah, TRELEGY ELLIPTA, MOUNJARO, OTEZLA, QULIPTA.

Industry payments across KS — which companies pay providers there.